Treace Medical Concepts, Inc. Share Price

Equities

TMCI

US89455T1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:03 01/06/2024 am IST 5-day change 1st Jan Change
5.875 USD +2.17% Intraday chart for Treace Medical Concepts, Inc. +13.86% -53.92%
Sales 2024 * 205M 17.14B Sales 2025 * 230M 19.17B Capitalization 364M 30.4B
Net income 2024 * -55M -4.59B Net income 2025 * -51M -4.25B EV / Sales 2024 * 1.78 x
Net Debt 2024 * 2.1M 175M Net Debt 2025 * 34.79M 2.9B EV / Sales 2025 * 1.74 x
P/E ratio 2024 *
-6.5 x
P/E ratio 2025 *
-6.94 x
Employees 516
Yield 2024 *
-
Yield 2025 *
-
Free-Float 68.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.17%
1 week+13.86%
Current month-0.09%
1 month-43.35%
3 months-56.29%
6 months-32.93%
Current year-53.92%
More quotes
1 week
4.93
Extreme 4.93
6.18
1 month
3.92
Extreme 3.92
11.33
Current year
3.92
Extreme 3.92
15.98
1 year
3.92
Extreme 3.92
27.41
3 years
3.92
Extreme 3.92
37.17
5 years
3.92
Extreme 3.92
37.17
10 years
3.92
Extreme 3.92
37.17
More quotes
Managers TitleAgeSince
Founder 52 01/14/01
Director of Finance/CFO 54 01/20/01
Compliance Officer 49 01/22/01
Members of the board TitleAgeSince
Director/Board Member 66 20/20/20
Director/Board Member 65 01/15/01
Chairman 77 01/14/01
More insiders
Date Price Change Volume
31/24/31 5.88 +2.26% 1,844,318
30/24/30 5.75 +8.90% 1,523,823
29/24/29 5.28 +4.55% 651,070
28/24/28 5.05 -2.13% 1,190,291
24/24/24 5.16 +2.38% 757,736

Delayed Quote Nasdaq, May 01, 2024 at 01:30 am IST

More quotes
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
5.88 USD
Average target price
6.833 USD
Spread / Average Target
+16.21%
Consensus